S-P2 Multiple Myeloma: Novel Agents Transplantation and Future Directions

Track: BMT Tandem "Scientific" Meeting
Thursday, February 14, 2013: 8:30 AM-10:00 AM
Ballroom A-H (Salt Palace Convention Center)
Chair:
Parameswaran N. Hari, MD
Autologous Transplant for Multiple Myeloma - Does Early Transplant Still Make Sense?
Parameswaran N. Hari, MD, MRCP, MS, Medical College of Wisconsin / CIBMTR

Consolidation or Maintenance after Transplantation
Philip L. McCarthy, MD, Roswell Park Cancer Institute

Novel Targets and Novel Agents
Nikhil C. Munshi, MD, Dana-Farber Cancer Institute